| 000 | 01462 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512080601.0 | ||
| 264 | 0 | _c19850531 | |
| 008 | 198505s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19850515)55:10<2342::aid-cncr2820551008>3.0.co;2-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColeman, M | |
| 245 | 0 | 0 |
_aHAC-Cytoxan (cyclophosphamide) chemotherapy for ovarian carcinoma. Alternating chemotherapy with intensification. _h[electronic resource] |
| 260 |
_bCancer _cMay 1985 |
||
| 300 |
_a2342-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAltretamine _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 700 | 1 | _aPasmantier, M W | |
| 700 | 1 | _aSilver, R T | |
| 773 | 0 |
_tCancer _gvol. 55 _gno. 10 _gp. 2342-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19850515)55:10<2342::aid-cncr2820551008>3.0.co;2-2 _zAvailable from publisher's website |
| 999 |
_c3926913 _d3926913 |
||